Report Detail

Request for Sample of this report

Pharma & Healthcare Global Dry Eye Syndrome Supply, Demand and Key Producers, 2026-2032

  • RnM4669129
    • |
  • 22 January, 2026
    • |
  • Global
    • |
  • 140 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

The global Dry Eye Syndrome market size is expected to reach $ 8474 million by 2032, rising at a market growth of 4.4% CAGR during the forecast period (2026-2032).
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment. In this report, we mainly study the drugs and eye drops for dry eye.
The Dry Eye Syndrome market is driven by the rising prevalence of dry eye conditions globally, fueled by aging populations, increased screen time, and lifestyle-related factors. The widespread use of digital devices has significantly contributed to eye strain and reduced blink rates, leading to a surge in dry eye cases, especially among younger demographics. Additionally, growing awareness of ocular health and improved diagnosis through advanced diagnostic tools have increased patient identification and treatment rates. The introduction of innovative therapies, including anti-inflammatory eye drops, tear-stimulating drugs, and device-based treatments, is also expanding the market landscape.
Despite growing demand, the Dry Eye Syndrome market faces several challenges, including underdiagnosis, variable symptoms, and limited long-term treatment efficacy. Many patients remain undiagnosed due to the overlap of symptoms with other ocular conditions and the subjective nature of the disease. Current treatments often offer only temporary relief rather than a cure, leading to poor adherence and patient dissatisfaction. Moreover, the development of new therapies is hindered by the complex pathophysiology of the condition, which involves both aqueous and evaporative components. Addressing these challenges requires improved diagnostic criteria, personalized treatment approaches, and increased investment in research and clinical trials.
Global Dry Eye Syndrome key players include Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, etc. Global top five manufacturers hold a share over 60%. North America is the largest market, with a share over 55%, followed by Europe and Asia-Pacific, both have a share over 35 percent. In terms of product, Anti-inflammatory Drugs is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital, followed by Retail Pharmacy.
This report studies the global Dry Eye Syndrome production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Dry Eye Syndrome and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dry Eye Syndrome that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Dry Eye Syndrome total production and demand, 2021-2032, (K Units)
Global Dry Eye Syndrome total production value, 2021-2032, (USD Million)
Global Dry Eye Syndrome production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Dry Eye Syndrome consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Dry Eye Syndrome domestic production, consumption, key domestic manufacturers and share
Global Dry Eye Syndrome production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Dry Eye Syndrome production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Dry Eye Syndrome production by Distribution Channel, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Dry Eye Syndrome market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, URSAPHARM, SIMILASAN, Akorn, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Dry Eye Syndrome market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Distribution Channel. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Dry Eye Syndrome Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Dry Eye Syndrome Market, Segmentation by Type:
Artificial Tears
Anti-inflammatory Drugs
Others
Global Dry Eye Syndrome Market, Segmentation by Distribution Channel:
Hospital
Retail Pharmacy
Others
Companies Profiled:
AbbVie
Alcon
Novartis
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
OmniVision Pharma
Rohto
Prestige Consumer Healthcare
LION
Kenvue (VISINE)
Key Questions Answered:
1. How big is the global Dry Eye Syndrome market?
2. What is the demand of the global Dry Eye Syndrome market?
3. What is the year over year growth of the global Dry Eye Syndrome market?
4. What is the production and production value of the global Dry Eye Syndrome market?
5. Who are the key producers in the global Dry Eye Syndrome market?
6. What are the growth factors driving the market demand?


1 Supply Summary

  • 1.1 Dry Eye Syndrome Introduction
  • 1.2 World Dry Eye Syndrome Supply & Forecast
    • 1.2.1 World Dry Eye Syndrome Production Value (2021 & 2025 & 2032)
    • 1.2.2 World Dry Eye Syndrome Production (2021-2032)
    • 1.2.3 World Dry Eye Syndrome Pricing Trends (2021-2032)
  • 1.3 World Dry Eye Syndrome Production by Region (Based on Production Site)
    • 1.3.1 World Dry Eye Syndrome Production Value by Region (2021-2032)
    • 1.3.2 World Dry Eye Syndrome Production by Region (2021-2032)
    • 1.3.3 World Dry Eye Syndrome Average Price by Region (2021-2032)
    • 1.3.4 North America Dry Eye Syndrome Production (2021-2032)
    • 1.3.5 Europe Dry Eye Syndrome Production (2021-2032)
    • 1.3.6 China Dry Eye Syndrome Production (2021-2032)
    • 1.3.7 Japan Dry Eye Syndrome Production (2021-2032)
    • 1.3.8 India Dry Eye Syndrome Production (2021-2032)
  • 1.4 Market Drivers, Restraints and Trends
    • 1.4.1 Dry Eye Syndrome Market Drivers
    • 1.4.2 Factors Affecting Demand
    • 1.4.3 Dry Eye Syndrome Major Market Trends

2 Demand Summary

  • 2.1 World Dry Eye Syndrome Demand (2021-2032)
  • 2.2 World Dry Eye Syndrome Consumption by Region
    • 2.2.1 World Dry Eye Syndrome Consumption by Region (2021-2026)
    • 2.2.2 World Dry Eye Syndrome Consumption Forecast by Region (2027-2032)
  • 2.3 United States Dry Eye Syndrome Consumption (2021-2032)
  • 2.4 China Dry Eye Syndrome Consumption (2021-2032)
  • 2.5 Europe Dry Eye Syndrome Consumption (2021-2032)
  • 2.6 Japan Dry Eye Syndrome Consumption (2021-2032)
  • 2.7 South Korea Dry Eye Syndrome Consumption (2021-2032)
  • 2.8 ASEAN Dry Eye Syndrome Consumption (2021-2032)
  • 2.9 India Dry Eye Syndrome Consumption (2021-2032)

3 World Manufacturers Competitive Analysis

  • 3.1 World Dry Eye Syndrome Production Value by Manufacturer (2021-2026)
  • 3.2 World Dry Eye Syndrome Production by Manufacturer (2021-2026)
  • 3.3 World Dry Eye Syndrome Average Price by Manufacturer (2021-2026)
  • 3.4 Dry Eye Syndrome Company Evaluation Quadrant
  • 3.5 Industry Rank and Concentration Rate (CR)
    • 3.5.1 Global Dry Eye Syndrome Industry Rank of Major Manufacturers
    • 3.5.2 Global Concentration Ratios (CR4) for Dry Eye Syndrome in 2025
    • 3.5.3 Global Concentration Ratios (CR8) for Dry Eye Syndrome in 2025
  • 3.6 Dry Eye Syndrome Market: Overall Company Footprint Analysis
    • 3.6.1 Dry Eye Syndrome Market: Region Footprint
    • 3.6.2 Dry Eye Syndrome Market: Company Product Type Footprint
    • 3.6.3 Dry Eye Syndrome Market: Company Product Application Footprint
  • 3.7 Competitive Environment
    • 3.7.1 Historical Structure of the Industry
    • 3.7.2 Barriers of Market Entry
    • 3.7.3 Factors of Competition
  • 3.8 New Entrant and Capacity Expansion Plans
  • 3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World

  • 4.1 United States VS China: Dry Eye Syndrome Production Value Comparison
    • 4.1.1 United States VS China: Dry Eye Syndrome Production Value Comparison (2021 & 2025 & 2032)
    • 4.1.2 United States VS China: Dry Eye Syndrome Production Value Market Share Comparison (2021 & 2025 & 2032)
  • 4.2 United States VS China: Dry Eye Syndrome Production Comparison
    • 4.2.1 United States VS China: Dry Eye Syndrome Production Comparison (2021 & 2025 & 2032)
    • 4.2.2 United States VS China: Dry Eye Syndrome Production Market Share Comparison (2021 & 2025 & 2032)
  • 4.3 United States VS China: Dry Eye Syndrome Consumption Comparison
    • 4.3.1 United States VS China: Dry Eye Syndrome Consumption Comparison (2021 & 2025 & 2032)
    • 4.3.2 United States VS China: Dry Eye Syndrome Consumption Market Share Comparison (2021 & 2025 & 2032)
  • 4.4 United States Based Dry Eye Syndrome Manufacturers and Market Share, 2021-2026
    • 4.4.1 United States Based Dry Eye Syndrome Manufacturers, Headquarters and Production Site (States, Country)
    • 4.4.2 United States Based Manufacturers Dry Eye Syndrome Production Value (2021-2026)
    • 4.4.3 United States Based Manufacturers Dry Eye Syndrome Production (2021-2026)
  • 4.5 China Based Dry Eye Syndrome Manufacturers and Market Share
    • 4.5.1 China Based Dry Eye Syndrome Manufacturers, Headquarters and Production Site (Province, Country)
    • 4.5.2 China Based Manufacturers Dry Eye Syndrome Production Value (2021-2026)
    • 4.5.3 China Based Manufacturers Dry Eye Syndrome Production (2021-2026)
  • 4.6 Rest of World Based Dry Eye Syndrome Manufacturers and Market Share, 2021-2026
    • 4.6.1 Rest of World Based Dry Eye Syndrome Manufacturers, Headquarters and Production Site (State, Country)
    • 4.6.2 Rest of World Based Manufacturers Dry Eye Syndrome Production Value (2021-2026)
    • 4.6.3 Rest of World Based Manufacturers Dry Eye Syndrome Production (2021-2026)

5 Market Analysis by Type

  • 5.1 World Dry Eye Syndrome Market Size Overview by Type: 2021 VS 2025 VS 2032
  • 5.2 Segment Introduction by Type
    • 5.2.1 Artificial Tears
    • 5.2.2 Anti-inflammatory Drugs
    • 5.2.3 Others
  • 5.3 Market Segment by Type
    • 5.3.1 World Dry Eye Syndrome Production by Type (2021-2032)
    • 5.3.2 World Dry Eye Syndrome Production Value by Type (2021-2032)
    • 5.3.3 World Dry Eye Syndrome Average Price by Type (2021-2032)

6 Market Analysis by Distribution Channel

  • 6.1 World Dry Eye Syndrome Market Size Overview by Distribution Channel: 2021 VS 2025 VS 2032
  • 6.2 Segment Introduction by Distribution Channel
    • 6.2.1 Hospital
    • 6.2.2 Retail Pharmacy
    • 6.2.3 Others
  • 6.3 Market Segment by Distribution Channel
    • 6.3.1 World Dry Eye Syndrome Production by Distribution Channel (2021-2032)
    • 6.3.2 World Dry Eye Syndrome Production Value by Distribution Channel (2021-2032)
    • 6.3.3 World Dry Eye Syndrome Average Price by Distribution Channel (2021-2032)

7 Company Profiles

  • 7.1 AbbVie
    • 7.1.1 AbbVie Details
    • 7.1.2 AbbVie Major Business
    • 7.1.3 AbbVie Dry Eye Syndrome Product and Services
    • 7.1.4 AbbVie Dry Eye Syndrome Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.1.5 AbbVie Recent Developments/Updates
    • 7.1.6 AbbVie Competitive Strengths & Weaknesses
  • 7.2 Alcon
    • 7.2.1 Alcon Details
    • 7.2.2 Alcon Major Business
    • 7.2.3 Alcon Dry Eye Syndrome Product and Services
    • 7.2.4 Alcon Dry Eye Syndrome Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.2.5 Alcon Recent Developments/Updates
    • 7.2.6 Alcon Competitive Strengths & Weaknesses
  • 7.3 Novartis
    • 7.3.1 Novartis Details
    • 7.3.2 Novartis Major Business
    • 7.3.3 Novartis Dry Eye Syndrome Product and Services
    • 7.3.4 Novartis Dry Eye Syndrome Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.3.5 Novartis Recent Developments/Updates
    • 7.3.6 Novartis Competitive Strengths & Weaknesses
  • 7.4 Santen Pharma
    • 7.4.1 Santen Pharma Details
    • 7.4.2 Santen Pharma Major Business
    • 7.4.3 Santen Pharma Dry Eye Syndrome Product and Services
    • 7.4.4 Santen Pharma Dry Eye Syndrome Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.4.5 Santen Pharma Recent Developments/Updates
    • 7.4.6 Santen Pharma Competitive Strengths & Weaknesses
  • 7.5 Johnson & Johnson
    • 7.5.1 Johnson & Johnson Details
    • 7.5.2 Johnson & Johnson Major Business
    • 7.5.3 Johnson & Johnson Dry Eye Syndrome Product and Services
    • 7.5.4 Johnson & Johnson Dry Eye Syndrome Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.5.5 Johnson & Johnson Recent Developments/Updates
    • 7.5.6 Johnson & Johnson Competitive Strengths & Weaknesses
  • 7.6 Bausch & Lomb
    • 7.6.1 Bausch & Lomb Details
    • 7.6.2 Bausch & Lomb Major Business
    • 7.6.3 Bausch & Lomb Dry Eye Syndrome Product and Services
    • 7.6.4 Bausch & Lomb Dry Eye Syndrome Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.6.5 Bausch & Lomb Recent Developments/Updates
    • 7.6.6 Bausch & Lomb Competitive Strengths & Weaknesses
  • 7.7 Thea pharmaceuticals
    • 7.7.1 Thea pharmaceuticals Details
    • 7.7.2 Thea pharmaceuticals Major Business
    • 7.7.3 Thea pharmaceuticals Dry Eye Syndrome Product and Services
    • 7.7.4 Thea pharmaceuticals Dry Eye Syndrome Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.7.5 Thea pharmaceuticals Recent Developments/Updates
    • 7.7.6 Thea pharmaceuticals Competitive Strengths & Weaknesses
  • 7.8 URSAPHARM
    • 7.8.1 URSAPHARM Details
    • 7.8.2 URSAPHARM Major Business
    • 7.8.3 URSAPHARM Dry Eye Syndrome Product and Services
    • 7.8.4 URSAPHARM Dry Eye Syndrome Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.8.5 URSAPHARM Recent Developments/Updates
    • 7.8.6 URSAPHARM Competitive Strengths & Weaknesses
  • 7.9 SIMILASAN
    • 7.9.1 SIMILASAN Details
    • 7.9.2 SIMILASAN Major Business
    • 7.9.3 SIMILASAN Dry Eye Syndrome Product and Services
    • 7.9.4 SIMILASAN Dry Eye Syndrome Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.9.5 SIMILASAN Recent Developments/Updates
    • 7.9.6 SIMILASAN Competitive Strengths & Weaknesses
  • 7.10 Akorn
    • 7.10.1 Akorn Details
    • 7.10.2 Akorn Major Business
    • 7.10.3 Akorn Dry Eye Syndrome Product and Services
    • 7.10.4 Akorn Dry Eye Syndrome Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.10.5 Akorn Recent Developments/Updates
    • 7.10.6 Akorn Competitive Strengths & Weaknesses
  • 7.11 United Laboratories
    • 7.11.1 United Laboratories Details
    • 7.11.2 United Laboratories Major Business
    • 7.11.3 United Laboratories Dry Eye Syndrome Product and Services
    • 7.11.4 United Laboratories Dry Eye Syndrome Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.11.5 United Laboratories Recent Developments/Updates
    • 7.11.6 United Laboratories Competitive Strengths & Weaknesses
  • 7.12 Sun Pharmaceutical
    • 7.12.1 Sun Pharmaceutical Details
    • 7.12.2 Sun Pharmaceutical Major Business
    • 7.12.3 Sun Pharmaceutical Dry Eye Syndrome Product and Services
    • 7.12.4 Sun Pharmaceutical Dry Eye Syndrome Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.12.5 Sun Pharmaceutical Recent Developments/Updates
    • 7.12.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
  • 7.13 Jianfeng Group
    • 7.13.1 Jianfeng Group Details
    • 7.13.2 Jianfeng Group Major Business
    • 7.13.3 Jianfeng Group Dry Eye Syndrome Product and Services
    • 7.13.4 Jianfeng Group Dry Eye Syndrome Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.13.5 Jianfeng Group Recent Developments/Updates
    • 7.13.6 Jianfeng Group Competitive Strengths & Weaknesses
  • 7.14 OmniVision Pharma
    • 7.14.1 OmniVision Pharma Details
    • 7.14.2 OmniVision Pharma Major Business
    • 7.14.3 OmniVision Pharma Dry Eye Syndrome Product and Services
    • 7.14.4 OmniVision Pharma Dry Eye Syndrome Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.14.5 OmniVision Pharma Recent Developments/Updates
    • 7.14.6 OmniVision Pharma Competitive Strengths & Weaknesses
  • 7.15 Rohto
    • 7.15.1 Rohto Details
    • 7.15.2 Rohto Major Business
    • 7.15.3 Rohto Dry Eye Syndrome Product and Services
    • 7.15.4 Rohto Dry Eye Syndrome Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.15.5 Rohto Recent Developments/Updates
    • 7.15.6 Rohto Competitive Strengths & Weaknesses
  • 7.16 Prestige Consumer Healthcare
    • 7.16.1 Prestige Consumer Healthcare Details
    • 7.16.2 Prestige Consumer Healthcare Major Business
    • 7.16.3 Prestige Consumer Healthcare Dry Eye Syndrome Product and Services
    • 7.16.4 Prestige Consumer Healthcare Dry Eye Syndrome Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.16.5 Prestige Consumer Healthcare Recent Developments/Updates
    • 7.16.6 Prestige Consumer Healthcare Competitive Strengths & Weaknesses
  • 7.17 LION
    • 7.17.1 LION Details
    • 7.17.2 LION Major Business
    • 7.17.3 LION Dry Eye Syndrome Product and Services
    • 7.17.4 LION Dry Eye Syndrome Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.17.5 LION Recent Developments/Updates
    • 7.17.6 LION Competitive Strengths & Weaknesses
  • 7.18 Kenvue (VISINE)
    • 7.18.1 Kenvue (VISINE) Details
    • 7.18.2 Kenvue (VISINE) Major Business
    • 7.18.3 Kenvue (VISINE) Dry Eye Syndrome Product and Services
    • 7.18.4 Kenvue (VISINE) Dry Eye Syndrome Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.18.5 Kenvue (VISINE) Recent Developments/Updates
    • 7.18.6 Kenvue (VISINE) Competitive Strengths & Weaknesses

8 Industry Chain Analysis

  • 8.1 Dry Eye Syndrome Industry Chain
  • 8.2 Dry Eye Syndrome Upstream Analysis
    • 8.2.1 Dry Eye Syndrome Core Raw Materials
    • 8.2.2 Main Manufacturers of Dry Eye Syndrome Core Raw Materials
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis
  • 8.5 Dry Eye Syndrome Production Mode
  • 8.6 Dry Eye Syndrome Procurement Model
  • 8.7 Dry Eye Syndrome Industry Sales Model and Sales Channels
    • 8.7.1 Dry Eye Syndrome Sales Model
    • 8.7.2 Dry Eye Syndrome Typical Distributors

9 Research Findings and Conclusion

    10 Appendix

    • 10.1 Methodology
    • 10.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Dry Eye Syndrome. Industry analysis & Market Report on Dry Eye Syndrome is a syndicated market report, published as Global Dry Eye Syndrome Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of Dry Eye Syndrome market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$4,480.00
    		$6,720.00
    		$8,960.00
    		3,463.04
    		5,194.56
    		6,926.08
    		4,170.88
    		6,256.32
    		8,341.76
    		684,051.20
    		1,026,076.80
    		1,368,102.40
    		378,112.00
    		567,168.00
    		756,224.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo